| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/14/2004 | CN1468247A Ethers of 7-desmethylrapamycin |
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468245A New process for the production of oxabispidines |
| 01/14/2004 | CN1468244A New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 01/14/2004 | CN1468242A Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 01/14/2004 | CN1468241A Heterocyclic compounds as ligands of the gabaa receptor |
| 01/14/2004 | CN1468112A The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/13/2004 | US6677334 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 01/13/2004 | US6677309 Anthracycline derivatives |
| 01/08/2004 | WO2004002992A1 Compounds |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | WO2004002490A2 Piperidine compounds as antibacterials |
| 01/08/2004 | WO2003076445A3 Microtubule stabilizing compounds |
| 01/08/2004 | WO2003055856A3 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 01/08/2004 | WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | DE10226943A1 Phenylaminopyrimidine und ihre Verwendung Phenylaminopyrimidine and their use |
| 01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1289997B1 Macrolides |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1465578A Indolinospirobenzoxazine compound, and synthesis method and use thereof |
| 01/07/2004 | CN1133429C Use of macrolide compounds for treatment of ARDS |
| 01/06/2004 | US6673809 Tricyclic compounds as MRP1-inhibitors |
| 01/06/2004 | US6673808 Pharmaceutical consisting of tacrolimus tricyclic compound, diethyl sebacate dissolution/absorption promoter, hydrophilic glycol pharmaceutical base, diethylene glycol monoethyl ether compatibilizer and cellulose or carboxyvinyl polymer thickener |
| 01/06/2004 | US6673793 Oxazinoquinolones useful for the treatment of viral infections |
| 01/06/2004 | US6673781 Inhibit secretory phospholipase a2-mediated fatty acid release; treating adult respiratory syndrome, pancreatitis, bronchial asthma, allergic rhinitis, chronic rheumatism, arteriosclerosis, cerebral infarction and psoriasis |
| 01/02/2004 | EP1373273A1 Process for preparing maytansinol |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
| 01/01/2004 | US20040002495 Lactam glycogen phosphorylase inhibitors and method of use |
| 01/01/2004 | US20040002488 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 12/31/2003 | WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 12/31/2003 | WO2003068980A3 Method for extracting a macrolide from biomatter |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | CN1463975A Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof |
| 12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
| 12/30/2003 | US6670507 Process for the preparation of aryloctanoyl amides |
| 12/30/2003 | US6670389 Laulimalide derivatives |
| 12/30/2003 | US6670373 Compounds and method for inhibiting MRP1 |
| 12/30/2003 | US6670364 Antagonists of MCP-1 function and methods of use thereof |
| 12/30/2003 | US6670358 Substituted thioacetamides |
| 12/30/2003 | US6670168 Recombinant Streptomyces hygroscopicus host cells that produce 17-desmethylrapamycin |
| 12/30/2003 | CA2102241C Use of macrolide compounds for eye diseases |
| 12/30/2003 | CA2099970C Composition for curing sjoegren syndrome disease |
| 12/30/2003 | CA2051399C Therapeutically useful 2-aminotetralin derivatives |
| 12/25/2003 | US20030236296 Novel interleukin-1beta converting enzyme inhibitors |
| 12/25/2003 | US20030236291 Antitumor agents |
| 12/25/2003 | US20030236265 Bactericides; autoimmune disease; antiinflammatory agents; administering a synergistic mixture of rifamycin and another antibiotic |
| 12/25/2003 | US20030236245 Helix mimetics and composition and methods related thereto |
| 12/25/2003 | US20030236240 Macrocycles useful in the treatment of alzheimer's disease |
| 12/25/2003 | US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections |
| 12/25/2003 | US20030235614 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 12/24/2003 | WO2003106460A1 Novel interleukin-1 beta converting enzyme inhibitors |
| 12/24/2003 | WO2003106450A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 12/24/2003 | WO2003106438A1 Synthesis of diazonamide "a" core |
| 12/24/2003 | WO2003105868A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003051299A3 Sulfhydryl rifamycins and uses thereof |
| 12/24/2003 | WO2003019697A3 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 12/24/2003 | CN1131869C 新的含三(噁唑)的细胞毒性大环内酯化合物 New cytotoxic macrolide compounds containing tris (oxazole) of |
| 12/24/2003 | CA2488884A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/23/2003 | US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide |
| 12/23/2003 | CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 12/23/2003 | CA2116387C Oxazolidinedione derivatives, their production and use |
| 12/18/2003 | WO2003104236A1 Calcitonin gene related peptide receptor antagonists |
| 12/18/2003 | WO2003104231A1 NOVEL INTERLEUKIN-1beta CONVERTING ENZYME INHIBITORS |
| 12/18/2003 | WO2003082192A3 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/18/2003 | WO2003050064B1 Mitotic kinesin inhibitors |
| 12/18/2003 | WO2002014536A9 Odulating multiple lineage kinase proteins |
| 12/18/2003 | US20030232821 Oxadiazine derivatives |
| 12/18/2003 | US20030232215 Organic Red Electro-Luminescent Device and Dopant |
| 12/17/2003 | EP0937075B1 New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. |
| 12/17/2003 | CN1462269A Fused azepine drivatives and their use as antidiuretic agents |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/11/2003 | WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 12/11/2003 | WO2003101956A1 Pharmaceutical combination |
| 12/11/2003 | WO2003101490A1 Drug composition containing calcium channel antagonist |
| 12/11/2003 | WO2003101445A1 Intravenous rifalazil formulation and methods of use thereof |
| 12/11/2003 | WO2003079980A3 Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof |
| 12/11/2003 | WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof |
| 12/11/2003 | WO2003022807A8 Medical devices containing rapamycin analogs |
| 12/11/2003 | US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants |
| 12/11/2003 | US20030229095 Sexual disorders |
| 12/11/2003 | US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 12/11/2003 | US20030229066 Central nervous system diosrders; psychological disorders |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | CA2486110A1 Pharmaceutical combination |
| 12/10/2003 | EP1368358A1 Isoxazoline derivatives as anti-depressants |
| 12/10/2003 | EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 12/10/2003 | EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 12/09/2003 | US6660862 Genetic engineering |
| 12/09/2003 | US6660740 Sorbitol dehydrogenase inhibitors |
| 12/09/2003 | US6660731 Pyrazole compounds useful as protein kinase inhibitors |
| 12/09/2003 | US6660526 Potassium fluoroionophore |
| 12/09/2003 | CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 12/04/2003 | WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |